Cargando…

The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury

Detalles Bibliográficos
Autor principal:	Vavougios, George D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	British Epilepsy Association. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261063/ https://www.ncbi.nlm.nih.gov/pubmed/32521503 http://dx.doi.org/10.1016/j.seizure.2020.05.014

Ejemplares similares

Host proteases as determinants of coronaviral neurotropism and virulence
por: Vavougios, George D.
Publicado: (2020)

Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection
por: Vavougios, George D.
Publicado: (2020)

Neurotropism of SARS-CoV 2: Mechanisms and manifestations
por: Conde Cardona, Giancarlos, et al.
Publicado: (2020)

Emerging neurotropic features of SARS-CoV-2
por: Zhan, Wen-Rong, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms
por: Zhou, Zhiqiang, et al.
Publicado: (2020)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS-CoV-2 related myocardial injury might explain the predisposition to preeclampsia with maternal SARS-CoV-2 infection
por: Giorgione, Veronica, et al.
Publicado: (2022)

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids
por: Ramani, Anand, et al.
Publicado: (2021)

The role of neurotropism in psychiatric patients with COVID-19
por: Diaz, Ailyn D., et al.
Publicado: (2020)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis
por: Vavougios, George D.
Publicado: (2020)

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2
por: Reinhold, Dirk, et al.
Publicado: (2021)

SARS-CoV-2 induced necrotizing pancreatitis
por: Maalouf, Rami George, et al.
Publicado: (2021)

SARS-CoV-2 induced necrotizing pancreatitis
por: Maalouf, Rami George, et al.
Publicado: (2021)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe
por: Vavougios, George D., et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients()
por: García Ramírez, Patricia, et al.
Publicado: (2022)

Cellular immunity against SARS-CoV-2 depends on the serological status
por: Pighi, Laura, et al.
Publicado: (2023)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses
por: Hu, Jingman, et al.
Publicado: (2020)

ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
por: Wang, Cheng, et al.
Publicado: (2021)

Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia?
por: Sarode, Gargi S., et al.
Publicado: (2021)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi
por: Vavougios, George D.
Publicado: (2020)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Not the Virus but Treatment and Immune Response Cause SARS-CoV-2-associated Neuropathy
por: Finsterer, Josef
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qk7mqnqm841q6ba40n0g1jm1ao